Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
01/15/2021 | Inhibitor Therapeutics, Inc. | HPPI | Other (acquisition) | Common Stock | 2.2M | $0.00 | $0 | | 01/15/2021 |
07/15/2020 | Inhibitor Therapeutics, Inc. | HPPI | Other (acquisition) | Common Stock | 3.2M | $0.00 | $0 | | 07/15/2020 |
01/15/2019 | Inhibitor Therapeutics, Inc. | HPPI | Other (acquisition) | Common Stock | 362.1k | $0.00 | $0 | | 01/15/2019 |
07/15/2018 | Inhibitor Therapeutics, Inc. | HPPI | Other (acquisition) | Common Stock | 184.8k | $0.00 | $0 | | 07/15/2018 |
07/05/2018 | Inhibitor Therapeutics, Inc. | HPPI | Purchase | Series B Convertible Preferred Stock | 2.3M | $0.00 | $0 | | 07/05/2018 |
07/05/2018 | Inhibitor Therapeutics, Inc. | HPPI | Purchase | Series B Warrants to Purchase Common Stock | 1.7M | $0.00 | $0 | | 07/05/2018 |
01/10/2018 | Inhibitor Therapeutics, Inc. | HPPI | Purchase | Series B Warrants to Purchase Common Stock | 2.6M | $0.00 | $0 | | 01/10/2018 |
01/10/2018 | Inhibitor Therapeutics, Inc. | HPPI | Purchase | Series B Convertible Preferred Stock | 3.5M | $0.00 | $0 | | 01/10/2018 |
12/19/2017 | Inhibitor Therapeutics, Inc. | HPPI | Purchase | Common Stock | 600k | $162,660.00 | $97596M | | 12/19/2017 |